139 related articles for article (PubMed ID: 10737739)
21. Residues affecting the catalysis and inhibition of rat lens aldose reductase.
Carper DA; Hohman TC; Old SE
Biochim Biophys Acta; 1995 Jan; 1246(1):67-73. PubMed ID: 7811733
[TBL] [Abstract][Full Text] [Related]
22. Stereospecific interaction of a novel spirosuccinimide type aldose reductase inhibitor, AS-3201, with aldose reductase.
Kurono M; Fujiwara I; Yoshida K
Biochemistry; 2001 Jul; 40(28):8216-26. PubMed ID: 11444967
[TBL] [Abstract][Full Text] [Related]
23. Crystal structure of CHO reductase, a member of the aldo-keto reductase superfamily.
Ye Q; Hyndman D; Li X; Flynn TG; Jia Z
Proteins; 2000 Jan; 38(1):41-8. PubMed ID: 10651037
[TBL] [Abstract][Full Text] [Related]
24. Correlation of binding constants and molecular modelling of inhibitors in the active sites of aldose reductase and aldehyde reductase.
Carbone V; Zhao HT; Chung R; Endo S; Hara A; El-Kabbani O
Bioorg Med Chem; 2009 Feb; 17(3):1244-50. PubMed ID: 19121944
[TBL] [Abstract][Full Text] [Related]
25. Aldose reductase as a target for drug design: molecular modeling calculations on the binding of acyclic sugar substrates to the enzyme.
De Winter HL; von Itzstein M
Biochemistry; 1995 Jul; 34(26):8299-308. PubMed ID: 7599122
[TBL] [Abstract][Full Text] [Related]
26. Aldose and aldehyde reductases: structure-function studies on the coenzyme and inhibitor-binding sites.
El-Kabbani O; Old SE; Ginell SL; Carper DA
Mol Vis; 1999 Sep; 5():20. PubMed ID: 10493777
[TBL] [Abstract][Full Text] [Related]
27. Identification of an aldose reductase inhibitor site by affinity labeling.
Kador PF; Lee YS; Rodriguez L; Sato S; Bartoszko-Malik A; Abdel-Ghany YS; Miller DD
Bioorg Med Chem; 1995 Oct; 3(10):1313-24. PubMed ID: 8564397
[TBL] [Abstract][Full Text] [Related]
28. Tyrosine-48 is the proton donor and histidine-110 directs substrate stereochemical selectivity in the reduction reaction of human aldose reductase: enzyme kinetics and crystal structure of the Y48H mutant enzyme.
Bohren KM; Grimshaw CE; Lai CJ; Harrison DH; Ringe D; Petsko GA; Gabbay KH
Biochemistry; 1994 Mar; 33(8):2021-32. PubMed ID: 8117659
[TBL] [Abstract][Full Text] [Related]
29. Ligand-induced fit affects binding modes and provokes changes in crystal packing of aldose reductase.
Koch C; Heine A; Klebe G
Biochim Biophys Acta; 2011 Sep; 1810(9):879-87. PubMed ID: 21684320
[TBL] [Abstract][Full Text] [Related]
30. Studies on the inhibitor-binding site of porcine aldehyde reductase: crystal structure of the holoenzyme-inhibitor ternary complex.
el-Kabbani O; Carper DA; McGowan MH; Devedjiev Y; Rees-Milton KJ; Flynn TG
Proteins; 1997 Oct; 29(2):186-92. PubMed ID: 9329083
[TBL] [Abstract][Full Text] [Related]
31. High-resolution crystal structure of aldose reductase complexed with the novel sulfonyl-pyridazinone inhibitor exhibiting an alternative active site anchoring group.
Steuber H; Zentgraf M; Podjarny A; Heine A; Klebe G
J Mol Biol; 2006 Feb; 356(1):45-56. PubMed ID: 16337231
[TBL] [Abstract][Full Text] [Related]
32. Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury.
Ramasamy R; Oates PJ; Schaefer S
Diabetes; 1997 Feb; 46(2):292-300. PubMed ID: 9000707
[TBL] [Abstract][Full Text] [Related]
33. Discovery of novel aldose reductase inhibitors using a protein structure-based approach: 3D-database search followed by design and synthesis.
Iwata Y; Arisawa M; Hamada R; Kita Y; Mizutani MY; Tomioka N; Itai A; Miyamoto S
J Med Chem; 2001 May; 44(11):1718-28. PubMed ID: 11356107
[TBL] [Abstract][Full Text] [Related]
34. Structure-based optimization of aldose reductase inhibitors originating from virtual screening.
Eisenmann M; Steuber H; Zentgraf M; Altenkämper M; Ortmann R; Perruchon J; Klebe G; Schlitzer M
ChemMedChem; 2009 May; 4(5):809-19. PubMed ID: 19301313
[TBL] [Abstract][Full Text] [Related]
35. Structure of aldehyde reductase holoenzyme in complex with the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
El-Kabbani O; Carbone V; Darmanin C; Oka M; Mitschler A; Podjarny A; Schulze-Briese C; Chung RP
J Med Chem; 2005 Aug; 48(17):5536-42. PubMed ID: 16107153
[TBL] [Abstract][Full Text] [Related]
36. Aldose reductase inhibition alone or combined with an adenosine A(3) agonist reduces ischemic myocardial injury.
Tracey WR; Magee WP; Ellery CA; MacAndrew JT; Smith AH; Knight DR; Oates PJ
Am J Physiol Heart Circ Physiol; 2000 Oct; 279(4):H1447-52. PubMed ID: 11009428
[TBL] [Abstract][Full Text] [Related]
37. Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites.
El-Kabbani O; Wilson DK; Petrash M; Quiocho FA
Mol Vis; 1998 Sep; 4():19. PubMed ID: 9756955
[TBL] [Abstract][Full Text] [Related]
38. In vitro aldose reductase inhibitory activity of some flavonyl-2,4-thiazolidinediones.
Daş-Evcimen N; Bozdağ-Dündar O; Sarikaya M; Ertan R
J Enzyme Inhib Med Chem; 2008 Jun; 23(3):297-301. PubMed ID: 18569331
[TBL] [Abstract][Full Text] [Related]
39. The crystal structure of the aldose reductase.NADPH binary complex.
Borhani DW; Harter TM; Petrash JM
J Biol Chem; 1992 Dec; 267(34):24841-7. PubMed ID: 1447221
[TBL] [Abstract][Full Text] [Related]
40. Structural and thermodynamic study on aldose reductase: nitro-substituted inhibitors with strong enthalpic binding contribution.
Steuber H; Heine A; Klebe G
J Mol Biol; 2007 May; 368(3):618-38. PubMed ID: 17368668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]